ICH Q2(R2) & Q14 Aim to Promote More Robust Analytical Processes, Greater Ease for Switching Analytical Methods Post Approval

About the Author

Bryan C. Castle, PhD
Associate Vice President - Synthetic Molecule Design & Development
Eli LIlly & Company
Bryan Castle, Ph.D., is a twenty plus year veteran of the pharmaceutical industry, who has a solid grounding in analytical sciences. He has experience in...